THC-O-acetate (THC-O)
A synthetic acetate ester of THC sold as a cannabinoid product, not a terpene, with serious safety concerns when vaped.
First, a correction: the topic was filed as a terpene, but THC-O-acetate is not a terpene. It's a semi-synthetic cannabinoid — an acetate ester of THC made in a lab, usually from hemp-derived CBD. Marketers call it 'three times stronger than THC' and 'spiritual' or 'psychedelic.' The human evidence for those claims is essentially nonexistent. What we do have is a real, documented lung injury risk when THC-O is vaped, because the acetate group can degrade into ketene. Treat it with caution.
Editorial note: this is not a terpene
THC-O-acetate (THC-O) is sometimes lumped into broad 'cannabis compounds' lists, but it is not a terpene and it is not naturally produced by the cannabis plant in any meaningful quantity Strong evidence. It is a semi-synthetic cannabinoid — specifically, the acetate ester of Δ9-tetrahydrocannabinol — produced by reacting THC (typically converted from hemp-derived CBD) with acetic anhydride [1][2]. Because the operator brief asked for a terpene-style article, we're keeping the infobox structure but flagging that the chemistry, pharmacology, and risk profile belong to the cannabinoid family, not the terpene family. For an actual terpene reference, see Myrcene or Beta-Caryophyllene.
What it is
THC-O-acetate is the O-acetyl ester of Δ9-THC: the free hydroxyl group on the THC molecule is replaced with an acetate group (–OCOCH₃) [1]. The compound was first synthesized and characterized in the mid-20th century; the US Army's Edgewood Arsenal studied it as a potential incapacitating agent in the 1940s–1970s [2]. It re-emerged commercially around 2020–2021 in the US 'hemp-derived cannabinoid' market, where chemists used acetic anhydride to acetylate Δ8-THC or Δ9-THC made from hemp CBD, and sold the result in vape carts, edibles, and tinctures [3].
As an ester, THC-O is considered a prodrug: it is thought to be hydrolyzed to active THC after ingestion, with the acetate group cleaved off by esterases [1][4]. This is the basis for claims that it is 'stronger' than THC, but published human pharmacokinetic data are extremely limited.
Where it's found
THC-O-acetate is not a natural constituent of cannabis at any concentration that has been reliably reported in peer-reviewed phytochemical surveys Strong evidence. Every commercial source is synthetic [3]. This contrasts with minor natural cannabinoids like CBG or THCV, which are biosynthesized by the plant.
In the consumer market, THC-O appears in:
- Vape cartridges (highest risk product — see safety section)
- Gummies and other edibles
- Tinctures
- Distillate blends, sometimes mixed with Δ8-THC or HHC without clear labeling [3]
Aroma and sensory profile
THC-O-acetate itself has no characteristic aroma comparable to terpenes; it is a viscous oil. Product aroma is driven by whatever terpenes (often re-introduced botanical or cannabis-derived terpenes) and residual solvents are added during formulation. There is no 'THC-O smell' in the way there is a Limonene or Pinene smell No data.
Effects: what the evidence actually shows
Marketing copy commonly claims THC-O is '3x stronger than THC' and produces 'psychedelic' or 'spiritual' effects. The honest summary:
- Potency claims: There are no published controlled human dosing studies of THC-O-acetate No data. The '3x' figure traces back to anecdotal user reports and old animal data of uncertain quality [2][3]. It should not be treated as established.
- 'Psychedelic' character: Reported anecdotally; no clinical confirmation, and no mechanism distinct from CB1 agonism has been demonstrated Anecdote.
- Delayed onset: Users consistently report a longer time-to-onset (20–60 minutes even when inhaled), which is consistent with prodrug hydrolysis but has not been rigorously characterized in humans Weak / limited[4].
- Intoxication and impairment: Behaves like a strong THC agonist once metabolized; expect THC-like impairment, anxiety risk, tachycardia, and cognitive effects Weak / limited[4].
In short: it gets people high, the high is THC-like, and the rest is folklore until clinical data exist.
Safety: the ketene problem
The most important fact about THC-O is a chemistry fact. When acetate esters of cannabinoids (THC-O-acetate and the parallel compound CBN-O-acetate) are heated to vaping temperatures, they can undergo thermal degradation that produces ketene (CH₂=C=O), a highly toxic gas that causes severe, delayed lung injury — mechanistically similar to the way vitamin E acetate was implicated in the 2019–2020 EVALI outbreak [5][6].
A 2023 peer-reviewed study by Meehan-Atrash and Strongin demonstrated ketene formation from THC-O-acetate and CBN-O-acetate under typical vaporizer conditions [5]. This is not a hypothetical concern; it is a reproducible chemistry result. The risk is specific to inhalation/vaping. Oral ingestion does not involve pyrolysis and does not generate ketene, though it carries the usual risks of any potent unregulated cannabinoid product (overconsumption, contamination, inaccurate labeling).
If someone is going to use THC-O at all, the harm-reduction position supported by the chemistry is: do not vape it.
Legal status
In February 2023, the US DEA stated in a letter that Δ8-THC-O and Δ9-THC-O do not occur naturally in cannabis and therefore cannot be considered hemp under the 2018 Farm Bill — making them controlled substances in DEA's view [7]. Some industry attorneys dispute this interpretation. State laws vary widely, and several states have explicitly banned THC-O along with other synthetic or semi-synthetic cannabinoids [3][7]. Check current local law before assuming anything.
Related compounds
THC-O sits in a family of semi-synthetic and synthetic cannabinoids that have moved into the US hemp-derived market since 2018:
- Delta-8 THC — isomer of THC, also typically made from hemp CBD
- HHC — hydrogenated THC analog
- HHC-O — the acetate ester of HHC, same ketene concern when vaped
- CBN — naturally occurring; CBN-O-acetate carries the same vaping hazard as THC-O
For naturally occurring plant compounds the operator may have meant to ask about, see Cannabinoids and Terpenes.
Sources
- Peer-reviewed Holland, M. L., et al. (2008). The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochemical Pharmacology, 75(4), 936–946. (Background on cannabinoid ester chemistry and prodrug behavior.)
- Reported Jikomes, N. (2021). What is THC-O-acetate? Leafly.
- Reported Jaeger, K. (2023). DEA Says THC-O Is A Controlled Substance, Not A Legal Hemp Product. Marijuana Moment.
- Peer-reviewed Tagen, M., & Klumpers, L. E. (2022). Review of delta-8-tetrahydrocannabinol (Δ8-THC): comparative pharmacology with Δ9-THC. British Journal of Pharmacology, 179(15), 3915–3933.
- Peer-reviewed Munger, K. R., Jensen, R. P., & Strongin, R. M. (2023). Vaping cannabinoid acetates leads to ketene formation. Chemical Research in Toxicology, 36(11), 1860–1864.
- Government Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products (EVALI). Background on vitamin E acetate and ketene-related lung injury.
- Reported US Drug Enforcement Administration letter to Rod Kight (February 13, 2023) regarding the status of delta-8-THC-O and delta-9-THC-O under the Controlled Substances Act. Reported via Kight on Cannabis.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...